Childhood emotional trauma significantly elevates psoriasis risk by disrupting immune responses, new research reveals. Early ...

Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern ...

Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...

Psoriasis affects about 2–3% of the global population translating to more than 125 million people worldwide according to the ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

From psoriasis to hair fall, Dr. Kushal Banerjee shares trusted homeopathic solutions for seven common skin conditions, gentle, natural, and effective.

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

Johnson & Johnson today announced findings from the U.S. dataset from the global ENCOMPASS study evaluating patient and healthcare provider (HCP) perspectives on barriers and unmet needs in psoriasis ...

Discover how Ayurveda promotes radiant skin through balance of doshas, nutrition, and lifestyle — blending ancient wisdom ...

Light therapy, once a dermatology staple, is now a mainstream beauty trend, with consumers seeking benefits like brighter ...

Phase 2 clinical study titled ‘Phase 2 Study Evaluating SGX302 (Synthetic Hypericin) in the Treatment of Mild-to-Moderate Psoriasis.’ The study aims to evaluate the effectiveness of SGX302, a topical ...

Alumis Inc. ((ALMS)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...